ARCHIVES

The Raghavan Experiment: With $500 Million to Draw On, An Iconoclast Invents Rational Care for a Gigantic System

This article is from The Cancer Letter archive.

Vol. 39 No. 01 | January 4, 2013

Download PDF Visit The Full Archive

Related Articles

Rauscher Explains Reasons for Treatment Switches

May 9, 1975

Docetaxel, Oxaliplatin Active Against Esophageal Cancer

June 30, 2006

NIH Review Division Considering Proposal For Clinical Oncology Study Section

October 10, 1997

NIH Seeking More Women, Minorities On Committees

November 9, 1979

Low Total Cholesterol Linked To Higher Risk Of Cancer; Higher HDL Associated With Decreased Risk Of Cancer

November 27, 2009

NIH Study Finds Sigmoidoscopy Reduces Colon Cancer Incidence and Mortality Rates

May 25, 2012